相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Engineering lymphocytes with RNAi
Srinivas Ramishetti et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
Victor A. Chow et al.
BLOOD (2018)
The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma
Bianca Simon et al.
EXPERIMENTAL DERMATOLOGY (2018)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma
Maarten A. Ligtenberg et al.
MOLECULAR THERAPY (2018)
Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer
Maarten Versteven et al.
FRONTIERS IN IMMUNOLOGY (2018)
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu et al.
ONCOIMMUNOLOGY (2018)
Involvement of Human Papillomaviruses in Cervical Cancer
Xuelian Wang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Efficacy of intracellular immune checkpoint-silenced DC vaccine
Danhong Wang et al.
JCI INSIGHT (2018)
Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity
Anugraha Rajagopalan et al.
MOLECULAR THERAPY (2017)
Clinical Proof of Concept for a Novel Hepatocyte-Targeting GaINAc-siRNA Conjugate
Tracy S. Zimmermann et al.
MOLECULAR THERAPY (2017)
Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics
Anna Maria Grimaldi et al.
NANOMEDICINE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion
Johan M. J. Van den Bergh et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Tregs: where we Are and what Comes Next?
Hai Zhao et al.
FRONTIERS IN IMMUNOLOGY (2017)
Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
Gao-Na Shi et al.
BIOMATERIALS (2017)
Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients
Luciano Castiello et al.
CLINICAL CANCER RESEARCH (2017)
Challenges and opportunities for siRNA-based cancer treatment
Tao Wang et al.
CANCER LETTERS (2017)
Recent progress in development of siRNA delivery vehicles for cancer therapy
Hyun Jin Kim et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
Maggie L. Bobbin et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
The present status and future prospects of peptide-based cancer vaccines
Masatoshi Hirayama et al.
INTERNATIONAL IMMUNOLOGY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Adjuvants for peptide-based cancer vaccines
Hiep Khong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
Mouldy Sioud et al.
CASE REPORTS IN MEDICINE (2016)
The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor- receptor on dendritic cells potentiates tumour antigen-specific CD8+ T cell immunity
Y. -H. Ahn et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Suppression of antigen presentation by IL-10
Sharad K. Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Efficient Nontoxic Delivery of PD-L1 and PD-L2 siRNA Into Dendritic Cell Vaccines Using the Cationic Lipid SAINT-18
Mieke W. H. Roeven et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam et al.
TRENDS IN MOLECULAR MEDICINE (2015)
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition
Roch Houot et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
Sofie Wilgenhof et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
The effect of combined IL10 siRNA and CpG ODN as pathogenmimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma
Pallab Pradhan et al.
BIOMATERIALS (2014)
Targeting human dendritic cells in situ to improve vaccines
Kartik Sehgal et al.
IMMUNOLOGY LETTERS (2014)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Somatic Mutations and Immunotherapy Outcome with CTLA-4 Blockade in Melanoma
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitro
Shuo Wang et al.
ONCOTARGETS AND THERAPY (2014)
Engineering better immunotherapies via RNA interference
Mouldy Sioud
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation
Willemijn Hobo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Dendritic Cells: Cellular Mediators for Immunological Tolerance
Chun Yuen J. Chung et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
Mouldy Sioud et al.
FASEB JOURNAL (2013)
Regulating naive and memory CD8 T cell homeostasis - a role for protein tyrosine phosphatases
Kelly A. Pike et al.
FEBS JOURNAL (2013)
Human CD1c+ Dendritic Cells Drive the Differentiation of CD103+ CD8+ Mucosal Effector T Cells via the Cytokine TGF-β
Chun I. Yu et al.
IMMUNITY (2013)
Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model
Xiufen Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
Mouldy Sioud et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
Jens Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The two hit hypothesis: An improved method for siRNA-mediated gene silencing in stimulated primary human T cells
Michael Freeley et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
Michael Platten et al.
CANCER RESEARCH (2012)
HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization
Jeremy Baudhuin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Abrogation of Src Homology Region 2 Domain-Containing Phosphatase 1 in Tumor-Specific T Cells Improves Efficacy of Adoptive Immunotherapy by Enhancing the Effector Function and Accumulation of Short-Lived Effector T Cells In Vivo
Ingunn M. Stromnes et al.
JOURNAL OF IMMUNOLOGY (2012)
Galectin-1 and-3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production
Anne Mobergslien et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer
Chunqing Guo et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Progress Toward In Vivo Use of siRNAs-II
Garrett R. Rettig et al.
MOLECULAR THERAPY (2012)
Adoptive Transfer of siRNA Cblb-Silenced CD8+ T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model
Reinhard Hinterleitner et al.
PLOS ONE (2012)
Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency
J. H. Kim et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
PD-L1 expression on tolerogenic APCs is controlled by STAT-3
Sabine J. Woelfle et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells
Willemijn Hobo et al.
BLOOD (2010)
RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells
Lisa Borkner et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera
A. DYBWAD et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
Calin O. Marian et al.
CLINICAL CANCER RESEARCH (2010)
Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
Karolina Palucka et al.
IMMUNITY (2010)
Origin and development of dendritic cells
Kang Liu et al.
IMMUNOLOGICAL REVIEWS (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
Daniel E. Speiser et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Epidermal Langerhans Cells Rapidly Capture and Present Antigens from C-Type Lectin-Targeting Antibodies Deposited in the Dermis
Vincent Flacher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
STAT3 Silencing in Dendritic Cells by siRNA Polyplexes Encapsulated in PLGA Nanoparticles for the Modulation of Anticancer Immune Response
Aws Alshamsan et al.
MOLECULAR PHARMACEUTICS (2010)
Enhanced Induction of HIV-specific Cytotoxic T Lymphocytes by Dendritic Cell-targeted Delivery of SOCS-1 siRNA
Sandesh Subramanya et al.
MOLECULAR THERAPY (2010)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. Van Tendeloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CTLA4 Silencing with siRNA Promotes Deviation of Th1/Th2 in Chronic Hepatitis B Patients
Yongsheng Yu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Immune regulation by 4-1BB and 4-1BBL: complexities and challenges
Chao Wang et al.
IMMUNOLOGICAL REVIEWS (2009)
Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase
Gro F. Flatekval et al.
IMMUNOLOGY (2009)
Reduced Cytotoxic Function of Effector CD8+ T Cells Is Responsible for Indoleamine 2,3-Dioxygenase-Dependent Immune Suppression
Hanzhong Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal
Brian T. Fife et al.
NATURE IMMUNOLOGY (2009)
Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
Huan-Yuan Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Does our Current Understanding of Immune Tolerance, Autoimmunity, and Immunosuppressive Mechanisms Facilitate the Design of Efficient Cancer Vaccines?
M. Sioud
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
Per O. Iversen et al.
TRANSLATIONAL ONCOLOGY (2009)
Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-127-35
Arvind Chhabra et al.
CLINICAL IMMUNOLOGY (2008)
SiRNA stabilization prolongs gene knockdown in primary T lymphocytes
Andrej Mantei et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
David Sancho et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Mark E. Kleinman et al.
NATURE (2008)
Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands
Gro Furset et al.
IMMUNOLOGY (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity
Jens Dannull et al.
BLOOD (2007)
Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs
Mouldy Sioud et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression
Marion Wobser et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Tolerogenic dendritic cells and regulatory T cells: A two-way relationship
Karsten Mahnke et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2007)
Adoptive T cell therapy for cancer in the clinic
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
G. Parmiani et al.
ANNALS OF ONCOLOGY (2007)
Design of bifunctional siRNAs: Combining immunostimulation and gene-silencing in one single siRNA molecule
Gro Furset et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Gene expression analysis in blood cells in response to unmodified and 2′-modified siRNAs reveals TLR-dependent and independent effects
Lina Cekaite et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Loss of Src homology region 2 domain-containing protein tyrosine phosphatase-1 increases CD8(+) T cell-APC conjugate formation and is associated with enhanced in vivo CTL function
Jean G. Sathish et al.
JOURNAL OF IMMUNOLOGY (2007)
Cutting edge: Induction of B7-H4 on APCs through IL-10: Novel suppressive mode for regulatory T cells
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2006)
Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts:: A central role for 2′-hydroxyl uridines in immune responses
Mouldy Sioud
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Tumor cell lines expressing the proteasome subunit isoform LMP7E1 exhibit immunoproteasome deficiency
S Heink et al.
CANCER RESEARCH (2006)
Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses
N Dakappagari et al.
JOURNAL OF IMMUNOLOGY (2006)
Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
M Sioud
JOURNAL OF MOLECULAR BIOLOGY (2005)
Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
V Hornung et al.
NATURE MEDICINE (2005)
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
LP Chen
NATURE REVIEWS IMMUNOLOGY (2004)
Toll-like receptors and dendritic cells: for whom the bug tolls
CRE Sousa
SEMINARS IN IMMUNOLOGY (2004)
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
MS Jeon et al.
IMMUNITY (2004)
Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity
L Shen et al.
NATURE BIOTECHNOLOGY (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
A Böhle et al.
JOURNAL OF UROLOGY (2003)
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
L Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
CTLA-4-Ig regulates tryptophan catabolism in vivo
U Grohmann et al.
NATURE IMMUNOLOGY (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)
S Saeboe-Larssen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome
BJ Van den Eynde et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Regulatory activity of autocrine IL-10 on dendritic cell functions
S Corinti et al.
JOURNAL OF IMMUNOLOGY (2001)
Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
H Jonuleit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
